Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,173.04, giving the company a market capitalization of 1.1T. It carries a P/E multiple of 40.36 and pays a dividend yield of 0.58%.
On 2026-08-05, Eli Lilly(LLY) stock traded between a low of $1,136.74 and a high of $1,216.94. Shares are currently priced at $1,173.04, which is +3.2% above the low and -3.6% below the high.
The Eli Lilly(LLY)'s current trading volume is 6.44M, compared to an average daily volume of 2.45M.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.
LLY News
...
Healthcare Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy. In this article XLV LLY VRTX GILD MCK Many healthcare and pharmaceutic...
Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company's portfolio of GLP-1 drugs continues to...
Analyst ratings
81%
of 31 ratingsMore LLY News
Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next for the $1 Trillion Drugmaker By Thomas Richmond Published Aug 5, 2:59PM EDT Q...
As of 11:50 AM ET, the Dow Jones Industrial Average (DJINDICES:^DJI) is up 0.80% to 54,521, and the S&P 500 (SNPINDEX:^GSPC) has climbed 0.03% to 7,738, putting...
Eli Lilly and Company LLY reported second-quarter 2026 adjusted earnings per share (“EPS”) of $8.38, which comprehensively beat the Zacks Consensus Estimate of...
The company’s obesity and diabetes franchise remained its biggest growth engine in the second quarter, with blockbuster GLP-1 drugs Mounjaro and Zepbound genera...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling over 100 points on Wednesday. The Dow traded up 0.79% to 54,514.16 while the...
Eli Lilly (LLY) is back in focus after reporting second quarter 2026 results and lifting its full year revenue outlook to US$85b to US$87b, giving investors fre...
GLP-1’s Drove Eli Lilly’s Record-Breaking Q2, but AI Will Be Its Future By Rich Duprey Published Aug 5, 9:50AM EDT Quick Read Eli Lilly Q2 revenue surged 48%...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.